PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting

Overview of attention for article published in Clinical Pharmacology & Therapeutics, September 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter: 17 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 57 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

Clinical Pharmacogenetic Testing and Application: 2024 Updated Guidelines by the Korean Society for Laboratory Medicine

Clinical guideline published by Korean Society for Laboratory Medicine (KSLM) on 17 Dec 2024

The Korean Society for Laboratory Medicine (KSLM) is dedicated to advancing laboratory medicine in South Korea. Established in 1980, it focuses on enhancing the status of laboratory specialists and improving public health through reliable diagnostic testing and academic collaboration.

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on 01 Jul 2024

The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.